These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3368804)

  • 21. Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Mar; 13(3):161-218. PubMed ID: 321205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants and pain.
    Micó JA; Ardid D; Berrocoso E; Eschalier A
    Trends Pharmacol Sci; 2006 Jul; 27(7):348-54. PubMed ID: 16762426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxepin's effects on chronic pain and depression: a controlled study.
    Hameroff SR; Weiss JL; Lerman JC; Cork RC; Watts KS; Crago BR; Neuman CP; Womble JR; Davis TP
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):47-53. PubMed ID: 6321454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclobenzaprine hydrochloride is a commonly prescribed centrally acting muscle relaxant, which is structurally similar to tricyclic antidepressants (TCAs) and differs from amitriptyline by only one double bond.
    Lofland JH; Szarlej D; Buttaro T; Shermock S; Jalali S
    Clin J Pain; 2001 Mar; 17(1):103-4. PubMed ID: 11289081
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.
    Rampello L; Nicoletti G; Raffaele R; Drago F
    Neuropsychobiology; 1995; 31(3):130-4. PubMed ID: 7609861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of tricyclic antidepressants for the control of chronic orofacial pain.
    Pettengill CA; Reisner-Keller L
    Cranio; 1997 Jan; 15(1):53-6. PubMed ID: 9586488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study.
    McCleane G
    Br J Clin Pharmacol; 2000 Jun; 49(6):574-9. PubMed ID: 10848721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tricyclic antidepressants on individual symptoms.
    Welner A; Welner Z; Robins E
    J Clin Psychiatry; 1980 Sep; 41(9):306-9. PubMed ID: 7410324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and predictors of response.
    Ward NG
    Spine (Phila Pa 1976); 1986 Sep; 11(7):661-5. PubMed ID: 2947334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tricyclic antidepressants in treatment of depression and chronic pain: analysis of the supporting evidence.
    Rosenblatt RM; Reich J; Dehring D
    Anesth Analg; 1984 Nov; 63(11):1025-32. PubMed ID: 6388415
    [No Abstract]   [Full Text] [Related]  

  • 33. Equivalency of tricyclic antidepressants in open-label neuropathic pain study.
    Liu WQ; Kanungo A; Toth C
    Acta Neurol Scand; 2014 Feb; 129(2):132-41. PubMed ID: 23937282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression.
    Ward NG; Bloom VL; Friedel RO
    Pain; 1979 Dec; 7(3):331-341. PubMed ID: 530739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reproducible efficacy of tricyclic antidepressant on chronic pain in an elderly patient with osteoporosis].
    Hibi S; Yamaguchi Y; Teramoto S; Yamamoto H; Eto M; Akishita M; Ouchi Y
    Nihon Ronen Igakkai Zasshi; 2007 Mar; 44(2):256-61. PubMed ID: 17527030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of tricyclic antidepressants in primary care.
    Blakey AF
    Acta Psychiatr Scand; 1999 Oct; 100(4):317. PubMed ID: 10510703
    [No Abstract]   [Full Text] [Related]  

  • 37. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricyclic antidepressants for medically ill geriatric patients.
    Small GW
    J Clin Psychiatry; 1989 Jul; 50 Suppl():27-31; discussion 32-3. PubMed ID: 2661549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double-blind comparative study on the effects of lofepramine and amitriptyline in depressive outpatients (author's transl)].
    Wright S; Herrmann L
    Arzneimittelforschung; 1976; 26(6):1167-9. PubMed ID: 786313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.
    Bryson HM; Wilde MI
    Drugs Aging; 1996 Jun; 8(6):459-76. PubMed ID: 8736630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.